Indication
Rubella
5 clinical trials
12 products
Clinical trial
A Phase Ⅳ, Randomized, Controlled, Open-label, Immunogenicity Study of Vero Cell-derived Inactivated Japanese Encephalitis Vaccine (JEV-I) Co-administered With Measles-Mumps-Rubella Vaccine (MMR)Status: Recruiting, Estimated PCD: 2024-09-30
Product
M-M-R VaccineClinical trial
A Phase I/II, Double-blind, Randomized, Active-controlled, Age De-escalation Trial to Assess Safety and Immunogenicity of a Measles Rubella Vaccine (MRV) Microneedle Patch (MRV-MNP) in Adults, MRV-primed Toddlers, and MRV-naïve InfantsStatus: Completed, Estimated PCD: 2022-11-23
Product
Measles Rubella VaccineProduct
MRV-MNPClinical trial
A Co-administration Study of Oral Cholera Vaccine (OCV), Typhoid Conjugate Vaccine (TCV), Measles and Rubella (MR) Vaccines in BangladeshStatus: Not yet recruiting, Estimated PCD: 2025-05-01
Product
Oral Cholera VaccineProduct
Typhoid Conjugate VaccineProduct
Measles and RubellaClinical trial
A Cross-Sectional and Open Pre-Post Interventional Study Evaluating Circulating and Mucosal Humoral and Cell-Mediated Immunity Following Measles, Mumps and Rubella (MMR) Vaccination in AdultsStatus: Recruiting, Estimated PCD: 2025-03-01
Product
MMR booster vaccinationClinical trial
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Varicella Vaccine and Measles, Mumps and Rubella Combined Vaccine in Shanghai, China: A Non-inferiority, Open-label, Randomised, Controlled, Phase 4 TrialStatus: Not yet recruiting, Estimated PCD: 2023-12-01